Elevated red cell distribution width (RDW) and adverse outcomes in patients with atrial fibrillation: new insights from a contemporary prospective study

Back

EHRA Premium Access

Elevated red cell distribution width (RDW) and adverse outcomes in patients with atrial fibrillation: new insights from a contemporary prospective study

Session: Atrial fibrillation epidemiology and clinical outcome

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Vitolo (Modena, IT)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Marco Vitolo

Modena Polyclinic Modena University Hospital, Modena (Italy)

1 presentation

0 follower

5 more presentations in this session

Major clinical outcomes in patients with symptomatic versus asymptomatic atrial fibrillation: a Bayesian and frequentist meta-analysis

Speaker: Doctor P. Karakasis (Thessaloniki, GR)

Global, regional and national burden of atrial fibrillation and flutter attributable to metabolic risks from 1990 to 2021: analysis of data from the global burden of disease study, 2021

Speaker: Doctor L. Ding (Beijing, CN)

Regional disparities in the care and outcomes of atrial fibrillation patients in a universal health care system: a population-based cohort study

Speaker: Doctor M. Shurrab (Sudbury, CA)

Impact of early rhythm control in young and middle-aged patients with depression or anxiety and new-onset atrial fibrillation

Speaker: Doctor S. Lee (Seoul, KR)

Impact of atrial fibrillation on cardiac arrest: a nationwide cohort study

Speaker: Miss D. Rajan (Copenhagen, DK)

Access the full session

Atrial fibrillation epidemiology and clinical outcome

Speakers: Doctor M. Vitolo, Doctor P. Karakasis, Doctor L. Ding, Doctor M. Shurrab, Doctor S. Lee...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources